Nellix EVAS System

Nellix is an investigational EndoVascular Aneurysm Sealing (EVAS) system designed for the treatment of infrarenal abdominal aortic aneurysm (AAA). EVAS is the next generation AAA therapy intended to treat more anatomies than currently approved endovascular stent graft devices, and is the only technology whose operating principle is centered around sealing the aneurysm sac.
This app is primarily aimed at medical professionals and those within the medical industry whom have an understanding of what an abdominal aortic aneurysm is and how it works. This app is intended to demonstrate how the Nellix system procedure works to treat such an aneurysm.

Augmented Reality Mode (AR)

The Augmented Reality application uses your device’s camera to display interactive 3D models with motion tracking. To experience this content in Augmented Reality, (AR Mode), download and print the Tracker Image Marker and orient your device's camera toward it. The Tracker Image Marker works best when flat on a table.
You can download marker at the following URL: http://tinyurl.com/hcpkz63.
To interact with the AR model, use the control icons located at the bottom of the screen. The right arrow icon steps through each process of the Nellix procedure with an animation. The circular arrow icon repeats the previous animation

About Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 80%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's website at www.endologix.com.